Use of taste-masking product, FLAVORx, to assist Thai children to ingest generic antiretrovirals
Tóm tắt
We evaluated whether FLAVORx helped thirty Thai children take opened capsule, crushed tablets and liquid generic ARVs with more ease. All children had excellent adherence, evaluated by PACTG Standard International Questionnaire and interviewing, before and after one month of FLAVORx. Eighty percent took ARV with more ease and wish to continue FLAVORx. Strawberry was the most popular flavor.
Tài liệu tham khảo
National ARV for people living with HIV AIDS (NAPHA project): Bureau of AIDS, TB and STI, Department of disease control, MOPH, Thailand 2006. Accessed 13 December 2006.,http://www.AIDSTHAI.org
Guideline for the use of antiretroviral agents in pediatric HIV infection March 24, 2005. AIDSinfo. 2005, Accessed 19 December 2005., http://aidsinfo.nih.gov/
Watson DC, Farley JJ: Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J. 1999, 18: 682-9. 10.1097/00006454-199908000-00006
Van dyke RB, Lee S, Johnson GM: Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Peadiatrics. 2002, 109: e61-10.1542/peds.109.4.e61.
Tuboi SH, Harrison LH, Sprinz E, Albernaz RK, Schechter M: Predictors of Virologic Failure in HIV-1-Infected Patients Starting Highly Active Antiretroviral Therapy in Porto Alegre, Brazil. J Acquir Immune Defic Syndr. 2005, 140: 324-328.
Maggiolo F, Ravasio L, Ripamonti D: Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clin Infect Dis. 2005, 1 (40): 158-63. 10.1086/426595. Epub 2004 Dec 6
Christine Jaderlund: The impact of a commercially available medication flavoring system (FLAVORx) on pediatric inpatients admitted to a children's Hospital. Poster presentation: 14th Pediatric Pharmacy Conference: PPAG Annual Meeting, Chicago, USA. October 9–12, 2005
Christine Jaderlund: The impact of a commercially available medication flavoring system (FLAVORx©) on pediatric inpatients admitted to a children's Hospital. J Pediatr Pharmacol Ther. 2005, 10 (2): 124-5.
NIAID PEDIATRIC AIDS CLINICAL TRIALS GROUP (PACTG) PEDIATRIC INTERNATIONAL ADHERENCE QUESTIONNAIRE Behavior/Identification QL5030 (P0000)/00-00-00. PEDIATRIC AIDS CLINICAL TRIALS GROUP 2005. Accessed 19 December 2005., https://www.fstrf.org/qol/pactg/ql5030.pdf
Revised Human Immunodeficiency Virus Pediatric Classification System: Clinical Categories, Centers for Disease Control and Prevention.1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR. 1994, 43 (RR-12): 1-10.
John G: Bartlett, Drug table 2. Antiretroviral agents, Target Serum Levels and CSF: Plasma ratio. John Hopkins University School of Medicine, Pocket Guide to adult HIV/AIDS treatment. 2005, Jan